If the final fortnight of July proved anything, it was that Australia's capital markets are open for business again.
The numbers certainly suggest they are.
More than $1 billion flowed into at least 60 ASX capital raisings between July 20 and August 4, producing the busiest reporting period of the year and signaling a marked improvement in investor sentiment after months of subdued activity.
However, the billion-dollar headline only tells part of the story. The real contest wasn't necessarily raising the money, it was competing for the available funds.
With dozens of companies approaching the market at the same time, institutional investors had the luxury of being selective. They backed projects moving towards production, acquisitions capable of creating value and management teams that could clearly explain how every new dollar would be spent. Others still found funding, but generally on much tougher terms.
The evidence was written into the pricing. Some companies barely needed to discount their stock before institutions reached for the cheque book. Others were forced to offer big concessions simply to complete their books. A select handful even convinced investors to subscribe at, or above, prevailing market prices, one of the strongest endorsements any company can receive.
The next three companies illustrate how judgement was dispensed by the market in the last fortnight under very different scenarios.
Visible gold in quartz veining at Saturn Metals Apollo Hill project 60 kilometres south east of Leonora in WA. Credit: File
Saturn Metals (ASX: STN)
Raised: $105 million
Price: $0.40
Discount: 11.1 per cent to the pre-raise closing price.
Post-raise performance +15%
Sole lead manager: Petra Capital
One of the reporting period's standout resource transactions belonged to Saturn Metals, which secured firm commitments for a $100 million placement before launching a fully underwritten $5 million share purchase plan to accelerate development of its Apollo Hill gold project in Western Australia.
Petra Capital assembled one of the strongest institutional books of the fortnight, with Canaccord playing second fiddle as a co-lead manager. Petra, who managed the book, also did the heavy lifting by underwriting the raise and subsequently putting most of it away. Saturn has been plugging away at its gold project in WA for years and looks like it has turned a corner now with what is probably one of Australia's more significant undeveloped heap leach gold projects. The size and quality of the book suggests the brokers had little difficulty finding institutional support despite the nine-figure raise.
An 11.1 per cent discount was sufficient to attract strong demand without signaling distress, an important distinction in today's market.
Since the raise, Saturn's shares have traded 15 per cent above the issue price, suggesting investors have strongly endorsed the company’s strategy. For Saturn, the raising wasn't simply about strengthening the balance sheet. It was another step towards becoming a mine developer rather than just another explorer.
Lotus Resources’ Kayelekera uranium project in Malawi. Credit: File
Lotus Resources (ASX: LOT)
Raised: $138.1 million
Price: $0.22
Discount: 66.7 per cent to the pre-raise closing price.
Post-raise performance -Steady
Lead Manager: Canaccord Genuity
If Saturn Metals demonstrated where institutions were prepared to back quality, Lotus Resources highlighted the price investors still demand for taking on additional risk.
The company assembled one of the reporting period's largest and most sophisticated funding packages, combining fresh equity, convertible notes and inventory-backed finance to support the restart of its Kayelekera uranium mine in Malawi.
Canaccord's clients were basking in the glow of one of the larger discounts to market in the $60 million equity raise portion which went out at 22c, a whopping 66.7 per cent below the previous closing price. On face value it looked brutal. Context, however, matters.
Restarting a uranium mine requires significant capital, carries execution risk and demands patient investors prepared to look well beyond the next quarter. The discount reflected those realities just as much as it reflected market conditions.
Despite the pricing, investors still committed more than $138 million to the Lotus raise, underlining continued confidence in uranium's longer-term outlook. Lotus shares traded as high as 38 cents post raise, giving Canaccord's nimble punter's a quick turn for those who took it before the slide back to 22.5 cents.
Vysarn (ASX: VYS)
Raised: $65.3 million
Price: $1.05
Discount: 0.5 per cent to the pre-raise closing price.
Post-raise performance +11%
Lead managers: Unified Capital Partners/Morgans/Canaccord Genuity
Canaccord also had its hand in the Vysarn raise recently along with Unified Capital Partners and Morgans.
The integrated water services company Vysarn tapped the market for a fully underwritten $65.3 million placement to help fund its acquisition of Welltech, a water and sewage management business. The deal was priced at just0.5 per cent below the previous closing price, one of the tightest discounts of the period.
In a market where many companies were still offering double-digit discounts simply to complete a book, Vysarn barely needed to sharpen its pencil.
The transaction, jointly managed by sole underwriter Unified Capital Partners, Morgans and Canaccord Genuity, suggested investors were far more interested in securing stock than negotiating a cheaper entry price.
Since the raise, Vysarn's stock has traded as high as $1.19, a nice little earner against the $1.05 entry price. It is currently holding up at $1.16.
Taken together, Saturn Metals, Lotus Resources and Vysarn probably tell the story of the fortnight better than any market statistic.
One attracted more than $100 million at a moderate discount to advance a flagship gold project. Another secured a transformational uranium funding package, but only after investors demanded a substantial margin of safety. The third barely needed to discount its stock at all. Three very different transactions. Three very different prices for capital. One unmistakable message. Investors are writing sizeable cheques again. They’re simply demanding much better reasons to do it and the price has to be spot on to reflect the risk.
At the lower end, Euroz Hartleys and Taylor Collison managed to put away a lazy $13 million for Pacgold at 15 cents a pop to accelerate work at its White Dam North gold project.
Priced at a 12 per cent discount, Pacgold's stock has held at the issue price and is still going out the door at 15c.
Petra Capital has seen a busy year with its clients taking a well-timed punt on Kalamazoo Resources nailing some big numbers during infill drilling at its Mt Olympus gold deposit in WA. Petra led an oversubscribed $8 million placement at 12 cents for Kalamazoo on July 20th and by the 3rd of August Kalamazoo had tabled some stellar numbers like 74m at 4.1g/t gold and 10m going a serious 49g/t gold. In fact, it was hard to see a dud number in the latest drill results and not hard to see why the stock is now trading at 17c a share, a handy 41% hike for the Petra faithful.
Casting the broking world aside, Western Mines Group quietly secured a modest $2.74 million at 16.3 cents per share, introducing cornerstone insto Lowell Resources Fund to its register. The arrival of a strategic 10.6 per cent shareholder shouts more about confidence in a project than the amount of money raised.
Since the placement, Western Mines has traded as high as 19.5 cents, although the longer-term significance of the cornerstone investment may ultimately prove more important than the market's initial reaction.
If one transaction in the last fortnight illustrated the value investors are still prepared to place on conviction, it belonged to Golden Dragon Mining.
While much of the market continued to rely on discounted placements, Chinese player Chengtun Gold filled its boots with Golden Dragon stock at, wait for it.......a 17.65 per cent premium with a$2.2 million hit out. The outcome will see Chengtun sitting purposefully on Golden Dragon's register with a 19.9 per cent stake.
Premium placements are like hen's teeth however, they generally occur when investors believe the market has materially undervalued the opportunity. Since completing the transaction, Golden Dragon has traded slightly below its 20-cent placement price at 18.5 cents, most likely just chump change for the Chinese.
Golden Dragon wasn't the only company able to command premium pricing though. Jade Gas ($11 million), Cambium Bio ($1 million) and RooLife Group ($1.06 million) also completed raisings above their prevailing market prices.
Not every company had the luxury of getting cap raises away at a premium, however.
The clients of West Perth mover and shaker Leeuwin Wealth are in the process of picking up a 2 for 1 entitlement offer in mining services firm Babylon Pump and Power at a 35 per cent discount to the last traded price when Babylon slipped off the ASX boards back in April this year.
Leeuwin is looking to plug about $12.7 million into Babylon at 5 cents a pop and will put its money where its mouth is with a $7.27 million underwriting package.
The market has not yet been able to deliver its verdict on the raise with Babylon's stock remaining suspended pending the outcome of the raise.
Meanwhile, biotech firm Radiopharm Theranostics put away $12.5 million through Bell Potter and is currently down 20 per cent, Dalaroo Metals slotted $2.5 million via 62 Capital and is currently up 15 per cent, Greenvale Energy placed $3.25 million via Alpine Capital Partners and is down 24 per cent and finally G50 Corp raised $26.25 million through Bell Potter and Morgans Corporate, with Hancock Prospecting tipping in $7.95 million, which is now worth 16 percent less, not that Hancock would notice.
Notably, July was also the busiest month for IPO’s so far in 2026 with nine new companies and one AI trust hitting the boards with retail investors continuing to prove they have an important role to play outside of providing sufficient shareholder spread for a company to be able to list.
In the final 2 weeks of July, Lux Copper Corp was up 30 per cent after its IPO, Ceretas Limited hiked128 per cent and Gwardar Resources shot the lights out at 187 per cent. It wasn't all peaches and cream however with Alurion Resources tracking down by about 27 per cent.
UBS Securities and MA Moelis along with Ord Minnett handled the biggest IPO for July which went to construction and infrastructure player FDC Consolidated with $400 million raised and is currently up 20per cent on its $3.00 subscription price.
All things considered, it appears as though the IPO market is back in the black.
Different sectors. Different commodities. Different strategies. The common thread was easy to spot. Companies that clearly articulated where the money was going generally found stronger support than those asking investors simply to extend the corporate runway.
One other truth quietly emerged as the fortnight unfolded; the market doesn’t waste time delivering its verdict. Some companies have already moved comfortably above their issue prices, suggesting punters believe management will deliver exactly what was promised.......well almost.
Brokers largely have an unenviable task - on the one hand they need to extract a decent discount to market for their investing clients and on the other hand, they need to keep the listed companies onside to secure a constant flow of business.
It is essentially a soft shoe shuffle and a high wire act that is not for the faint hearted. Convincing your listed client that the discount was appropriate when the market ran the stock hard post the raise is no mean feat. At the end of the day however, a stock that is heading north tends to be the only tonic that matters.
Is your ASX-listed company doing something interesting? Contact: matt.birney@businessnews.com.au
By Murray Ward
